Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Invited Commentary: Augmented Pelvic US: Path Forward to Reduce Delays in Diagnosis of Endometriosis
Jha, Priyanka , VanBuren, Wendaline M. , VanBuren, Wendaline M , Jha, Priyanka

RadioGraphics | November 21, 2024 | Volume: 44 | Issue: 12 | Pages: No page available

10.1148/rg.240214 | PMID 39570782 Get It

Macrolide-Resistant Mycoplasma pneumoniae, North Dakota 2024
Douvoyiannis, Miltiadis , Rothstein, Tanner E. , Patel, Robin , Patel, Robin

Journal of the Pediatric Infectious Diseases Society | November 21, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.1093/jpids/piae117 | PMID 39570300 Get It

Abstract A cluster of macrolide-resistant Mycoplasma pneumoniae -causing community-acquired pneumonia was observed in children in North Dakota in 2024. Suspicion was raised by non-response to macrolides, with confirmation via a polymerase-chain reaction assay. Prompt improvement occurred after the initiation of alternative antibiotics.
American Society of Hematology: building a comprehensive minority recruitment and retention professional program
Rollins, Margo , Warsame, Rahma , Smith, Melody , Rouce, Rayne H. , Avalos, Belinda R. , Johnson, Cage S., López, José A. , Thompson, Alexis A. , Fanning, Lisa, Frustace, Patricia, Roche, Keelin F. , Havre, Nathalie van , Mack, Devon, Flowers, Christopher R. , Rollins, Margo R , Warsame, Rahma , Thompson, Alexis A , Terrell, Deirdra R , Smith, Melody , Molina, Arturo , Terrell, Deirdra R.

Blood Advances | November 21, 2024 | Volume: 8 | Issue: 24 | Pages: 6237-6247

10.1182/bloodadvances.2024013519 | PMID 39570294 Get It

Abstract In 2003, the Institute of Medicine noted the need to improve workforce diversity. The American Society of Hematology (ASH) responded by developing the Minority Recruitment Initiative (MRI) to recruit diverse physicians/scientists into hematology. We evaluated the outcomes of the program. From 2004 to 2022, there were 405 awardees. Compared with national estimates, MRI awardees were less likely to discontinue their degree programs. MRI graduate student awardees had 0% attrition (97.5% confidence interval [CI], 10.6), whereas the national minority graduate student attrition was 36%. Medical student awardees had 2.2% (95% CI, 0.61-5.6) attrition, compared with the minority medical school attrition of 5.6%. Awardees were more likely than expected to pursue hematology-oncology (5.7% minority national estimate) because 14.4% (95% CI, 8.1-23.0) of medical student awardees and 88.5% (95% CI, 70.0-97.6) of early career awardees remain in the field. ASH has developed a successful program, but continued efforts are needed to advance equity in hematology.
Validation of automated detection of REM sleep without atonia using in-laboratory and in-home recordings
Levendowski, Daniel J. , Lewis, Simon J.G. , Finstuen, Thomas, Mosovsky, Sherri, Parikh, Hersh, Anderson, Jack , Walsh, Christine M. , Lee‐Iannotti, Joyce , Finstuen, Thomas J, St Louis, Erik K, Lewis, Simon J G , Chahine, Lana M. , Galbiati, Andrea , Berka, Chris , Parikh, Hersh, Neylan, Thomas C. , Ferini-Strambi, Luigi , Boeve, Bradley F. , Louis, Erik K. St.

Journal of Clinical Sleep Medicine | November 21, 2024 | Volume: 21 | Issue: 3 | Pages: 583-592

10.5664/jcsm.11488 | PMID 39569509 Get It

Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities study
Wang, Wendy , Lutsey, Pamela L. , Reyes, Jorge L. , Mosley, Thomas H. , Johansen, Michelle C. , Alonso, Álvaro , Jack, Clifford R. , Solomon, Scott D. , Shah, Amil, Wasserman, Bruce A. , Shah, Amil M. , Johansen, Michelle C , Jack, Clifford R , Alonso, Alvaro , Lutsey, Pamela L , Shah, Amil , Inciardi, Riccardo M. , Gottesman, Rebecca F. , Solomon, Scott David , Chen, Lin Y.

European Journal of Neurology | November 21, 2024 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/ene.16549 | PMID 39569699 Get It

AbstractBackground and purposeLower left atrial (LA) function is associated with higher dementia risk and may be mechanistically linked through vascular brain injury, an established correlate for higher dementia risk. Using data from the Atherosclerosis Risk in Communities study, we assessed the cross‐sectional association between LA function and brain magnetic resonance imaging (MRI) markers of vascular brain injury.MethodsWe included 1488 participants who were free of prevalent dementia, stroke, or atrial fibrillation and who underwent a two‐dimensional echocardiogram and brain MRI in 2011–2013 (mean [± standard deviation] age 76 [± 5] years, 60% female, 27% Black). LA function measures (reservoir, conduit, contractile strain) were assessed in quartiles. Brain MRI measures included cerebral microbleeds, brain infarcts, and white matter hyperintensity (WMH) volume. Logistic regression was used for dichotomous outcomes. Linear regression was used for WMH volume.ResultsOverall, 343 (23%) and 344 participants (23%) had ≥1 cerebral microbleed or brain infarct. After multivariable adjustments, the lowest LA reservoir and conduit strain quartiles (vs. highest quartile) were associated with higher odds of the presence of ≥1 cerebral microbleed (odds ratios [95% confidence intervals] 1.78 [1.42–2.22] and 1.52 [1.22–1.90]). Compared to the highest quartile, participants in the lowest LA conduit strain quartile had 1.51 (95% confidence interval 1.22–1.88) times higher odds of having ≥1 brain infarct. Lower LA contractile strain was associated with lower odds of brain infarcts. No association with WMH volume was noted.ConclusionsWe found that LA reservoir and conduit strain were associated with cerebral microbleeds and brain infarcts. Lower LA function may be linked to dementia risk via vascular brain injury. Prospective studies are needed to confirm these findings.
Intraoperative Electrical Stapedius Reflex Testing to Monitor Cochlear Nerve Integrity during Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation
Carlson, Matthew L. , Daher, Ghazal S. , Khandalavala, Karl R. , Lohse, Christine M. , Neff, Brian A., Driscoll, Colin L. W., Peris-Celda, Maria, Link, Michael J. , Saoji, Aniket A. , Peris‐Celda, Maria , Gompel, Jamie J. Van

Otology & Neurotology | November 21, 2024 | Volume: 46 | Issue: 1 | Pages: 60-66

10.1097/mao.0000000000004379 | PMID 39666744 Get It

Objective To compare the utility of intraoperative electrically evoked auditory brainstem response (eABR) and electrically evoked stapedial reflex testing (eSRT) for cochlear nerve integrity monitoring during simultaneous translabyrinthine resection of vestibular schwannoma (VS) and cochlear implantation. Study design Historical cohort study. Setting Tertiary academic referral center. Patients Eleven patients (12 cases) who underwent translabyrinthine tumor resection with simultaneous placement of a standard, unmodified cochlear implant (CI). Intervention A CI placed at the beginning of the operation before tumor resection to facilitate intraoperative cochlear nerve monitoring through a CI-delivered electrical stimulus. Main outcome measure Correlation of intraoperative monitoring outcomes with postoperative CI performance. Results Among the 12 cases (median age, 47 years), eABR waveforms were present at the conclusion of tumor resection in 10, including 6 that achieved open set speech perception. Of the 2 cases with negative eABR, 1 achieved open set speech perception. By contrast, of the 8 cases with a positive eSRT response, 7 achieved open set speech perception. Of the 4 cases with a negative eSRT response, none achieved open set speech perception. The 3 cases that did not receive auditory stimulation included 2 with positive and 1 with negative eABR; all 3 had a negative eSRT response. Conclusions Intraoperative eSRT using an unmodified CI is a promising new method for monitoring the integrity of the cochlear nerve during simultaneous VS resection. eSRT response at the conclusion of tumor resection strongly correlated with CI open set speech capacity. Although still useful, eABR was less reliable at predicting postoperative hearing outcomes in this series.
Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study
Martin, Robert C.G. , White, Rebekah R. , Bilimoria, Malcolm M., Kluger, Michael D. , Hammil, Chet W., Heithaus, Robert Evans , Welling, Theodore H., Chan, Carlos H.F. , Chan, Carlos H F , White, Rebekah R , Iannitti, David A. , Polanco, Patricio Marcelo , Cleary, Sean P.

Cancers | November 21, 2024 | Volume: 16 | Issue: 23 | Pages: 3894

10.3390/cancers16233894 | PMID 39682087 Get It

Background/Objectives: Overall survival for patients with Stage 3 pancreatic ductal adenocarcinoma (PDAC) remains limited, with a median survival of 12 to 15 months. Irreversible electroporation (IRE) is a local tumor ablation method that induces cancerous cell death by disrupting cell membrane homeostasis. The DIRECT Registry study was designed to assess the effectiveness and safety of IRE when combined with standard of care (SOC) treatment for Stage 3 PDAC versus SOC alone in a real-world setting after at least 3 months of induction chemotherapy; Methods: Patients with Stage 3 PDAC treated with IRE plus SOC or SOC alone were prospectively enrolled in a multicenter registry study. Enrollment required 3 months of active multi-agent chemotherapy with no progression before enrollment. Endpoints were 30- and 90-day mortality and adverse events (AEs). Results: Eighty-seven IRE and 27 SOC subjects were enrolled in the registry. Mean ages were 64.0 ± 8.4 and 66.4 ± 9.9 years, and mean anterior/posterior tumor diameters were 2.2 ± 0.7 cm and 3.2 ± 1.3 for the IRE and SOC groups respectively (p = 0.0066). All IRE procedures were performed using an open approach. The 90-day all-cause mortality was 5/83 (6.0%) and 2/27 (7.4%) for the IRE and SOC groups, respectively. Two subjects in the IRE group died from treatment-related complications, and one patient in the SOC group died due to chemotherapy-related complications. Conclusions: Initial results from the DIRECT registry study indicate the use of IRE for curative intent tumor ablation in combination with induction chemotherapy has equivalent morbidity and mortality rates when compared to standard-of-care chemotherapy alone.
Developing a Carotid Pseudoaneurysm Model in Swine
Banaskiewicz, Karolina , Price, Colin, Benike, Amy, Dragomir‐Daescu, Dan , Oliver, Alexander A , Treffalls, Rebecca N, Dragomir-Daescu, Dan, Treffalls, Rebecca N. , Price, Colin, Morrison, Jonathan J.

Journal of Endovascular Therapy | November 21, 2024 | Volume: 33 | Issue: 3 | Pages: 1148-1156

10.1177/15266028241297066 | PMID 39569621 Get It

Background: Traumatic carotid artery pseudoaneurysms (PSAs) represent a vascular anomaly with potential for serious complications, including stroke. Traditional treatments involve endovascular stenting, which may not be ideally suited to otherwise healthy vessels that have the potential to remodel. Given the limitations of smaller animal models in replicating human vasculature and the need for improved treatment modalities, this study introduces a novel swine model for the creation and evaluation of carotid PSAs. Methods: The PSAs were created from bovine dura and anastomosed in an end-to-side fashion to bilateral carotid arteries. The PSAs were radiologically followed up post-operatively and were harvested at 3 and 10 days for histological analysis. Results: Pseudoaneurysms were successfully created in both animals without intra-operative or immediate post-operative complications. Radiological analysis showed well-perfused PSAs with intra-aneurysmal turbulence, hemodynamically mimicking human carotid artery PSAs. There was no evidence of thrombus or arterial stenosis. Histological examinations revealed thrombus maturation and tight anastomosis of the PSA sac with the native artery. Conclusions: This PSA swine model offers a replicable, cost-effective, and easily implemented tool with the potential to advance carotid PSA management and educational efforts in vascular surgery. Clinical Impact The model presented in this methodology paper allows for a standardized PSA animal model allowing for the standardization of a clinical entity which is frequently heterogenenous in morphology. This can allow for the development of new therapies or provide a ground truth for computer modelling for further in silico study.
Bevacizumab: The future of chronic subdural hematoma
Verma, Yash , Abdelghaffar, Mariam , Verma, Onam , Gajjar, Aryan, Ghozy, Sherief , Kallmes, David F. , Ghozy, Sherief , Gajjar, Aryan

Interventional Neuroradiology | November 21, 2024 | Volume: 32 | Issue: 4 | Pages: 1954-1965

10.1177/15910199241298727 | PMID 39569567 Get It

Bevacizumab (BCZ), commercially known as Avastin, is a monoclonal antibody that targets vascular endothelial growth factor (VEGF). Initially recognized as a breakthrough in oncology, it has since gained FDA approval for various ocular conditions and more recently, for the treatment of glioblastoma multiforme (GBM). Bevacizumab's ability to inhibit excessive neovascularization suggests it may have a potential role in treating chronic subdural hematomas (cSDH). Recent studies have shown that the pathophysiology of cSDH is more complex than previously understood, with VEGF concentrations in subdural fluid significantly exceeding those in serum, contributing to the high recurrence rates. Intra-arterial administration of bevacizumab has shown promising results in recent case series against chronic subdural hematoma, and may be a viable alternative to middle meningeal artery embolization. If successful, this treatment could significantly decrease the rate of recurrence and result in lower rates of severe neurological complications such as visual loss. This literature review explores the connection between bevacizumab and cSDH, focusing on the pharmacological, safety, and delivery aspects of this approach while summarizing the current evidence supporting its use.